News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,538 Results
Type
Article (50938)
Company Profile (333)
Press Release (670267)
Section
Business (208852)
Career Advice (2036)
Deals (36025)
Drug Delivery (102)
Drug Development (84425)
Employer Resources (170)
FDA (16554)
Job Trends (15135)
News (354284)
Policy (33482)
Tag
Academia (2711)
Alliances (51148)
Alzheimer's disease (1330)
Approvals (16525)
Artificial intelligence (221)
Bankruptcy (366)
Best Places to Work (11860)
Biotechnology (247)
Breast cancer (251)
Cancer (1900)
Cardiovascular disease (136)
Career advice (1696)
CAR-T (139)
Cell therapy (393)
Clinical research (67886)
Collaboration (718)
Compensation (380)
COVID-19 (2622)
C-suite (179)
Data (1708)
Diabetes (222)
Diagnostics (6575)
Earnings (86716)
Employer resources (146)
Events (114699)
Executive appointments (590)
FDA (17511)
Funding (637)
Gene therapy (273)
GLP-1 (677)
Government (4480)
Healthcare (19309)
Infectious disease (2740)
Inflammatory bowel disease (128)
Interviews (316)
IPO (16735)
Job creations (3729)
Job search strategy (1447)
Layoffs (470)
Legal (8122)
Lung cancer (280)
Manufacturing (251)
Medical device (13389)
Medtech (13394)
Mergers & acquisitions (19674)
Metabolic disorders (585)
Neuroscience (1757)
NextGen: Class of 2025 (6738)
Non-profit (4656)
Northern California (2196)
Obesity (322)
Opinion (213)
Patents (179)
People (58294)
Phase I (21232)
Phase II (29781)
Phase III (22220)
Pipeline (798)
Postmarket research (2814)
Preclinical (9137)
Radiopharmaceuticals (259)
Rare diseases (347)
Real estate (6058)
Regulatory (22700)
Research institute (2482)
Resumes & cover letters (352)
Southern California (1892)
Startups (3741)
United States (19482)
Vaccines (649)
Weight loss (222)
Date
Today (87)
Last 7 days (776)
Last 30 days (2732)
Last 365 days (35181)
2025 (5444)
2024 (36106)
2023 (40960)
2022 (52221)
2021 (56782)
2020 (55088)
2019 (47720)
2018 (35971)
2017 (33332)
2016 (32835)
2015 (38838)
2014 (32633)
2013 (28046)
2012 (30314)
2011 (30854)
2010 (29172)
Location
Africa (767)
Arizona (218)
Asia (39894)
Australia (6708)
California (5050)
Canada (1758)
China (425)
Colorado (228)
Connecticut (241)
Europe (87934)
Florida (735)
Georgia (172)
Illinois (472)
Indiana (273)
Maryland (778)
Massachusetts (3850)
Michigan (201)
Minnesota (349)
New Jersey (1420)
New York (1442)
North Carolina (879)
Northern California (2196)
Ohio (174)
Pennsylvania (1145)
South America (1147)
Southern California (1892)
Texas (736)
Utah (155)
Washington State (490)
721,538 Results for "cancer genetics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools
February 28, 2025
·
3 min read
Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that Genetics in Medicine, an official journal of the American College of Medical Genetics and Genomics (ACMG), published a new study validating RiskScore®, Myriad’s breast cancer risk assessment tool integrated into its MyRisk® Hereditary Cancer Test.
June 3, 2024
·
4 min read
Phase III
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial
Protagonist Therapeutics notches a milestone in its pact with Takeda for rusfertide. New data show that many patients with a chronic blood cancer taking the drug didn’t need to have their blood removed to bring down dangerously high hemocrit levels.
March 3, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology
January 22, 2025
·
4 min read
Press Releases
Myriad Genetics and Lumea Collaborate to Enhance Access to the Prolaris Biomarker and MyRisk Hereditary Cancer Tests through BxLink Integration
February 5, 2025
·
4 min read
Press Releases
Datar Cancer Genetics Unveils Next Generation Multi-Analyte, AI-Powered Decision Support Platform for Personalized Treatment of Difficult-to-Treat Cancers.
February 3, 2025
·
4 min read
Press Releases
NCCN Announces New Gastrointestinal Cancer Research Grants in Collaboration with Taiho Oncology, Inc.
February 26, 2025
·
4 min read
Press Releases
Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.
February 12, 2025
·
6 min read
Cancer
Cancer Pipelines Shrink as Incyte, iTeos Cut Candidates Following Disappointing Data
Incyte is abandoning its ALK2 blocker zilurgisertib, which it was trialing for myelofibrosis-associated anemia, while iTeos will deprioritize the development of inupadenant after it failed to meet the biotech’s clinical bar in a Phase II study of metastatic non-small cell lung cancer.
December 13, 2024
·
2 min read
·
Tristan Manalac
Business
Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 CountriesNew sponsored testing program leverages Myriad’s MyChoice Tests for patients with high-grade serous ovarian cancer
Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced a collaboration with GSK aimed at improving access to homologous recombination deficiency diagnostic testing for high-grade serous ovarian cancer patients.
June 11, 2024
·
3 min read
1 of 72,154
Next
